Tower View Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.88K Sell
19
-63
-77% -$21.6K ﹤0.01% 168
2026
Q1
$28.8K Buy
82
+63
+332% +$22.5K 0.01% 111
2025
Q4
$6.13K Hold
19
﹤0.01% 148
2025
Q3
$5.25K Buy
19
+1
+6% +$290 ﹤0.01% 149
2025
Q2
$5.15K Hold
18
﹤0.01% 170
2025
Q1
$5.7K Sell
18
-9
-33% -$2.66K ﹤0.01% 150
2024
Q4
$7.09K Hold
27
﹤0.01% 140
2024
Q3
$8.7K Hold
27
﹤0.01% 139
2024
Q2
$8.44K Hold
27
﹤0.01% 134
2024
Q1
$7.68K Hold
27
﹤0.01% 140
2023
Q4
$8K Buy
27
+9
+50% +$2.45K 0.01% 128
2023
Q3
$5K Hold
18
﹤0.01% 137
2023
Q2
$4K Buy
+18
New +$4.18K ﹤0.01% 149

Other funds holding AMGN

Tower View Wealth Management's AMGN Position: Q2 2026 in Review

Tower View Wealth Management reduced its Amgen (AMGN) stake by 77% in Q2 2026, selling an estimated $21.6K and leaving 19 shares worth $6.88K. The position accounts for ﹤0.01% of the portfolio, ranked #168.

Tower View Wealth Management first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. The position peaked at $28.8K in Q1 2026. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Tower View Wealth Management held 19 shares of Amgen worth $6.88K as of Q2 2026.
  • Tower View Wealth Management sold 63 Amgen shares in Q2 2026, an estimated $21.6K.
  • Amgen made up ﹤0.01% of Tower View Wealth Management's portfolio in Q2 2026, its #168 holding.
  • Tower View Wealth Management first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
  • Tower View Wealth Management's Amgen position peaked at $28.8K in Q1 2026.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Tower View Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.